Myriad Genetics (MYGN) Assets (2016 - 2025)
Historic Assets for Myriad Genetics (MYGN) over the last 16 years, with Q3 2025 value amounting to $728.1 million.
- Myriad Genetics' Assets fell 3266.44% to $728.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $728.1 million, marking a year-over-year decrease of 3266.44%. This contributed to the annual value of $1.0 billion for FY2024, which is 1037.07% down from last year.
- According to the latest figures from Q3 2025, Myriad Genetics' Assets is $728.1 million, which was down 3266.44% from $677.3 million recorded in Q2 2025.
- Over the past 5 years, Myriad Genetics' Assets peaked at $1.4 billion during Q2 2021, and registered a low of $677.3 million during Q2 2025.
- For the 5-year period, Myriad Genetics' Assets averaged around $1.1 billion, with its median value being $1.2 billion (2023).
- Its Assets has fluctuated over the past 5 years, first crashed by 190.05% in 2023, then crashed by 3758.18% in 2025.
- Quarter analysis of 5 years shows Myriad Genetics' Assets stood at $1.3 billion in 2021, then decreased by 9.24% to $1.2 billion in 2022, then dropped by 4.35% to $1.1 billion in 2023, then fell by 10.37% to $1.0 billion in 2024, then decreased by 29.15% to $728.1 million in 2025.
- Its Assets stands at $728.1 million for Q3 2025, versus $677.3 million for Q2 2025 and $1.0 billion for Q1 2025.